Research programme: light-activated antibody- drug conjugates - PhotoBiotics

Drug Profile

Research programme: light-activated antibody- drug conjugates - PhotoBiotics

Alternative Names: ProstaLite Photo-ImmunoConjugate; ProstaLite PIC

Latest Information Update: 28 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator PhotoBiotics
  • Class Antibodies; Drug conjugates; Immunoconjugates
  • Mechanism of Action Photosensitisers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Prostate cancer

Most Recent Events

  • 28 Jul 2016 Research programme: light-activated antibody- drug conjugates - PhotoBiotics is available for licensing - http://www.photobiotics.com/partner-opportunities.shtml
  • 28 Jul 2016 Preclinical trials in Prostate cancer in United Kingdom (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top